Table 2 Treatment characteristics of both cohorts

Treatment days

< 5

1

2

17

32.7

5

7

13.7

27

69.2

6–7

42

82.4

8

28.8

> 7

1

2

0

_

Completed treatment ^a

Yes

50

98

51

98.1

No

1

2

1

1.9

Interruption of treatment

Yes

1

2

2

3.8

Reason

Adverse event

1

100

1

50

Improvement of condition

_

1

50

Concomitant medication

Yes

41

80.4

38

65.4

No

10

19.6

18

34.6